HCP
Dymista Menu
HCP

Dymista® Spray Pattern Comparison

One airway, one disease: An expert report into the true impact of hayfever and asthma

Developed by MEDA in partnership with Allergy UK

Dymista® is indicated for the relief of symptoms of moderate to severe seasonal and perennial allergic rhinitis if monotherapy with either intranasal antihistamine or glucocorticoid is not considered sufficient.

Adverse events should be reported.
Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to MEDA: pv@remove-this.medapharma.co.uk

UK/DYM/14/0070b(2) September 2015

Login

Log in

CloseClose

Sign in to Dymista

Don't have a Dymista account?

The website you are trying to access is designed for UK Healthcare Professionals only - the content is not designed for the general public.


Are you a UK Healthcare Professional?

Yes No
Why do I need to answer this?

No, I am not a HCP

Sorry, you do not have the authorization to enter this webpage.

Go back Go back
close-icon